These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25379273)

  • 41. Neurotensin: dual roles in psychostimulant and antipsychotic drug responses.
    Dobner PR; Deutch AY; Fadel J
    Life Sci; 2003 Jun; 73(6):801-11. PubMed ID: 12801600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of neurotensin with dopamine-containing neurons in the central nervous system.
    Ervin GN; Nemeroff CB
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S53-69. PubMed ID: 3074341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.
    Tschumi CW; Beckstead MJ
    Eur J Neurosci; 2019 Mar; 49(6):784-793. PubMed ID: 29405480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases.
    Martini A; Cordella A; Pisani A; Mercuri NB; Guatteo E
    Neuropharmacology; 2019 Sep; 155():76-88. PubMed ID: 31128122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of neurotensin in the immune and neuroendocrine modulation of normal and abnormal enteric function.
    Kalafatakis K; Triantafyllou K
    Regul Pept; 2011 Oct; 170(1-3):7-17. PubMed ID: 21549161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
    Radke JM; Owens MJ; Ritchie JC; Nemeroff CB
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11462-4. PubMed ID: 9736759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The roles of neurotensin and its analogues in pain.
    Feng YP; Wang J; Dong YL; Wang YY; Li YQ
    Curr Pharm Des; 2015; 21(7):840-8. PubMed ID: 25345606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Distribution of neurotensin-like immunoreactivity (NTLI) and neurotensin receptor in the rat brain and effects of various drugs on NTLI concentration and NT receptor in the rat cerebral cortex].
    Masuda T; Fujimoto H; Kawai H; Saito S
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):362-74. PubMed ID: 2842204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.
    Prus AJ; Hillhouse TM; LaCrosse AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():78-84. PubMed ID: 24275076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide systems and schizophrenia.
    LaCrosse AL; Olive MF
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):619-32. PubMed ID: 23574175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
    Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
    Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurotensin and dopamine interactions.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Pharmacol Rev; 2001 Dec; 53(4):453-86. PubMed ID: 11734615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative sequencing of the proneurotensin gene and association studies in schizophrenia.
    Austin J; Hoogendoorn B; Buckland P; Speight G; Cardno A; Bowen T; Williams N; Spurlock G; Sanders R; Jones L; Murphy K; McCarthy G; McGuffin P; Owen MJ; O'Donovan MC
    Mol Psychiatry; 2000 Mar; 5(2):208-12. PubMed ID: 10822351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
    Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms.
    Hanson GR; Singh N; Merchant K; Johnson M; Bush L; Gibb JW
    Ann N Y Acad Sci; 1992; 668():165-72. PubMed ID: 1361111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol.
    Hanson GR; Bush LG; Taylor VL; Gibb JW; Davis K; Schmidt CJ
    Brain Res Bull; 1997; 42(3):211-9. PubMed ID: 8995332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S; Davis C; Jones S; Li M
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.